Asset and derivatives pricing, enterprise valuation, and monetization strategy consulting
Our independent price verification and consulting services focus on the valuation and monetization of intellectual property in the life sciences and medical technology industries. We also provide expert analysis and testimony for a variety of transactional, regulatory, tax, accounting, and fiduciary purposes.
We have done work on behalf of life sciences and medical technology firms including Genentech, Carl Zeiss Meditec, Siemens Medical, Apria Healthcare, Millennium Pharmaceuticals, Cynvec, and Applied Cardiac Systems, as well as investors including Khosla Ventures, KPCB, DFJ Gotham, and Index Ventures.
Areas of Practice
We help inventors, entrepreneurs, and the enterprise find the best paths to monetization. We identify technology-specific value inflection points and assist in articulating a pathway to exit.
We are experts at valuing intellectual property — on a standalone basis, and in relation to the enterprise and its strategic objectives. We specialize in pricing common stock, convertible and preferred securities, warrants, options, debt and lease instruments, partnership interests, and intangible assets.
We provide expert analysis and testimony in both life sciences-related and nonrelated legal cases. Our services are cost efficient and effective.